The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...

Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s ...

While glucose, or sugar, is a well-known fuel for the brain, Weill Cornell Medicine researchers have demonstrated that ...

A year-long clinical trial has found that Ambroxol, a cough syrup commonly sold across Europe, could potentially slow the ...

The MRC CoRE in Restorative Neural Dynamics will receive up to £50 million over 14 years. The centre team will investigate ...

Discover the importance of vital statistics for a healthy society, India's role in chemotherapy drugs, and unresolved Covid ...

A new study shows that creatine supplementation can restore memory, reduce brain damage, and boost energy metabolism in aging ...